Frankfurt - Delayed Quote EUR

ME Therapeutics Holdings Inc. (Q9T.F)

Compare
4.8600
+0.0200
+(0.41%)
At close: February 7 at 3:29:02 PM GMT+1
Loading Chart for Q9T.F
DELL
  • Previous Close 4.8400
  • Open 4.8400
  • Bid 4.1800 x --
  • Ask 5.7000 x --
  • Day's Range 4.8400 - 4.8600
  • 52 Week Range 0.8000 - 5.5000
  • Volume 2
  • Avg. Volume 109
  • Market Cap (intraday) 140.709M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: Q9T.F

View More

Performance Overview: Q9T.F

Trailing total returns as of 2/7/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

Q9T.F
88.37%
S&P/TSX Composite index
3.34%

1-Year Return

Q9T.F
519.11%
S&P/TSX Composite index
21.40%

3-Year Return

Q9T.F
847.37%
S&P/TSX Composite index
19.61%

5-Year Return

Q9T.F
847.37%
S&P/TSX Composite index
43.28%

Compare To: Q9T.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: Q9T.F

View More

Valuation Measures

As of 2/7/2025
  • Market Cap

    141.01M

  • Enterprise Value

    140.19M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    142.52

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: Q9T.F

View More